← FDA DRUG APPROVALS

FDA ANDA · ANDA040847

GLYCOPYRROLATE

Sponsor: CHARTWELL RX

APPLICATION
ANDA040847
TYPE
ANDA
ORIGINAL APPROVAL
2008-03-21
LATEST ACTION
2026-01-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

GLYCOPYRROLATEPrescription
GLYCOPYRROLATE 2MG · TABLET · ORAL
GLYCOPYRROLATEPrescription
GLYCOPYRROLATE 1MG · TABLET · ORAL

Approval history

2026-01-19Labeling · Supplement 5 · standardAP
2012-12-06Labeling · Supplement 1 · standardAP
2008-03-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →